Women should be advised that current use of CHC (combined hormonal contraception) is associated with a small increased risk of breast cancer which reduces with time after stopping CHC (1).
A study (n=9498 incident invasive breast cancer [BC]; 18,171 matched controls) found current or recent hormonal contraceptive use linked to similarly increased BC risk, regardless of whether oral combined, POP, or injectable/implant/intrauterine device of progestogen was last used (2):
Reference:
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page